Harmony Retained Earnings from 2010 to 2024

HRMY Stock

USD 35.75 0.92 2.64%

Harmony Biosciences Retained Earnings yearly trend continues to be fairly stable with very little volatility. Retained Earnings will likely drop to about -150.4 M in 2024. Retained Earnings is the cumulative amount of net income that Harmony Biosciences Holdings retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2019-09-30

Previous Quarter

-93.4 M

Current Value

-47.3 M

Quarterly Volatility

154.5 M

Covid

Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 28.4 M, Depreciation And Amortization of 14.7 M or Interest Expense of 17.9 M, as well as many indicators such as Price To Sales Ratio of 3.14, Dividend Yield of 0.0 or PTB Ratio of 4.32. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.

Check out the analysis of Harmony Biosciences Correlation against competitors.

Latest Harmony Biosciences' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Harmony Biosciences Holdings over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Harmony Biosciences' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harmony Biosciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (143.28 M)

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Retained Earnings

Timeline

Harmony Retained Earnings Regression Statistics

	Arithmetic Mean	(274,303,990)
	Coefficient Of Variation	(36.65)
	Mean Deviation	72,232,404
	Median	(242,673,000)
	Standard Deviation	100,528,866
	Sample Variance	10106.1T
	Range	344.9M
	R-Value	(0.13)
	Mean Square Error	10686.8T
	R-Squared	0.02
	Significance	0.63
	Slope	(3,021,171)
	Total Sum of Squares	141484.7T

Harmony Retained Earnings History

	2024	-150.4 M
	2023	-143.3 M
	2022	-272.1 M
	2021	-453.6 M
	2020	-488.2 M
	2019	-422.9 M

Other Fundumenentals of Harmony Biosciences

Retained Earnings Total Equity

Harmony Biosciences Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Common Stock	Property Plant Equipment	Long Term Debt	Intangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Current Deferred Revenue	Short Long Term Debt	Short Term Debt
Total Assets		0.87	0.91	-0.12	0.02	0.66	0.93	0.95	0.99	-0.92	0.94	-0.51	-0.98	0.91	0.9	-0.61	0.9	-0.51	0.88	0.63	0.63
Total Stockholder Equity	0.87		0.96	-0.41	0.42	0.8	0.71	0.92	0.87	-0.8	0.88	-0.78	-0.83	0.76	0.74	-0.85	0.93	-0.78	0.91	0.82	0.82
Net Tangible Assets	0.91	0.96		-0.42	0.26	0.67	0.79	0.96	0.94	-0.92	0.94	-0.68	-0.87	0.87	0.86	-0.76	0.88	-0.68	0.84	0.71	0.71
Net Debt	-0.12	-0.41	-0.42		-0.77	-0.21	0.13	-0.19	-0.2	0.16	-0.26	0.38	-0.04	-0.01	0.0	0.37	-0.3	0.38	-0.27	-0.41	-0.41
Retained Earnings	0.02	0.42	0.26	-0.77		0.41	-0.28	0.04	0.04	0.14	0.11	-0.48	0.13	-0.25	-0.26	-0.45	0.36	-0.48	0.42	0.51	0.51
Accounts Payable	0.66	0.8	0.67	-0.21	0.41		0.61	0.7	0.6	-0.53	0.5	-0.92	-0.64	0.52	0.49	-0.93	0.84	-0.92	0.75	0.97	0.97
Total Liab	0.93	0.71	0.79	0.13	-0.28	0.61		0.91	0.9	-0.92	0.79	-0.47	-0.97	0.95	0.95	-0.55	0.75	-0.47	0.69	0.55	0.55
Net Invested Capital	0.95	0.92	0.96	-0.19	0.04	0.7	0.91		0.96	-0.97	0.92	-0.66	-0.96	0.95	0.94	-0.75	0.87	-0.66	0.81	0.7	0.7
Total Current Assets	0.99	0.87	0.94	-0.2	0.04	0.6	0.9	0.96		-0.94	0.96	-0.49	-0.96	0.91	0.91	-0.59	0.88	-0.49	0.86	0.6	0.6
Capital Stock	-0.92	-0.8	-0.92	0.16	0.14	-0.53	-0.92	-0.97	-0.94		-0.89	0.52	0.93	-0.99	-0.98	0.61	-0.75	0.52	-0.67	-0.55	-0.55
Net Working Capital	0.94	0.88	0.94	-0.26	0.11	0.5	0.79	0.92	0.96	-0.89		-0.42	-0.91	0.85	0.84	-0.54	0.85	-0.42	0.85	0.51	0.51
Common Stock	-0.51	-0.78	-0.68	0.38	-0.48	-0.92	-0.47	-0.66	-0.49	0.52	-0.42		0.51	-0.49	-0.46	0.99	-0.72	1.0	-0.59	-0.95	-0.95
Property Plant Equipment	-0.98	-0.83	-0.87	-0.04	0.13	-0.64	-0.97	-0.96	-0.96	0.93	-0.91	0.51		-0.95	-0.94	0.61	-0.85	0.51	-0.81	-0.59	-0.59
Long Term Debt	0.91	0.76	0.87	-0.01	-0.25	0.52	0.95	0.95	0.91	-0.99	0.85	-0.49	-0.95		0.99	-0.58	0.71	-0.49	0.63	0.51	0.51
Intangible Assets	0.9	0.74	0.86	0.0	-0.26	0.49	0.95	0.94	0.91	-0.98	0.84	-0.46	-0.94	0.99		-0.55	0.68	-0.46	0.63	0.47	0.47
Long Term Debt Total	-0.61	-0.85	-0.76	0.37	-0.45	-0.93	-0.55	-0.75	-0.59	0.61	-0.54	0.99	0.61	-0.58	-0.55		-0.8	0.99	-0.67	-0.96	-0.96
Capital Surpluse	0.9	0.93	0.88	-0.3	0.36	0.84	0.75	0.87	0.88	-0.75	0.85	-0.72	-0.85	0.71	0.68	-0.8		-0.72	0.93	0.85	0.85
Deferred Long Term Liab	-0.51	-0.78	-0.68	0.38	-0.48	-0.92	-0.47	-0.66	-0.49	0.52	-0.42	1.0	0.51	-0.49	-0.46	0.99	-0.72		-0.59	-0.95	-0.95
Current Deferred Revenue	0.88	0.91	0.84	-0.27	0.42	0.75	0.69	0.81	0.86	-0.67	0.85	-0.59	-0.81	0.63	0.63	-0.67	0.93	-0.59		0.72	0.72
Short Long Term Debt	0.63	0.82	0.71	-0.41	0.51	0.97	0.55	0.7	0.6	-0.55	0.51	-0.95	-0.59	0.51	0.47	-0.96	0.85	-0.95	0.72		1.0
Short Term Debt	0.63	0.82	0.71	-0.41	0.51	0.97	0.55	0.7	0.6	-0.55	0.51	-0.95	-0.59	0.51	0.47	-0.96	0.85	-0.95	0.72	1.0

Click cells to compare fundamentals

About Harmony Biosciences Financial Statements

Harmony Biosciences investors use historical fundamental indicators, such as Harmony Biosciences' Retained Earnings, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Retained Earnings	-143.3 M	-150.4 M
Retained Earnings Total Equity	-312.9 M	-328.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Harmony Stock Analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC